How Much Does Mounjaro Cost? (2026 Pricing Guide)

Eduard Cristea
Eduard Cristea
Published: |Updated:

See this year’s GLP-1 Black Friday prices, checked against what we recorded.

Skip the $1,112 list price

Compounded tirzepatide from $129/mo — tirzepatide as its active ingredient, not FDA-approved, no insurance hassle.

Visit Embody →

Quick Answer

How much does Mounjaro cost? Mounjaro costs $1,112 a month at list price in 2026, the same at every dose. You pay as little as $25 with commercial insurance that covers it plus Lilly's savings card, $499 with commercial insurance that doesn't cover it, or $499 a month self-pay through LillyDirect. Compounded tirzepatide, which is not FDA-approved, starts at $129 a month from tracked telehealth providers.

Mounjaro List Price
$1,112/mo
LillyDirect Self-Pay
$499/mo
Covered + Lilly Card
$25/mo
Compounded Tirzepatide
$129/mo

Lilly prices read on lilly.com/lillydirect and mounjaro.lilly.com on October 13, 2026. Compounded prices are the lowest advertised rates from tracked providers in our GLP-1 Price Index (November 11, 2026). How we verify: methodology.

Mounjaro tirzepatide injection pen

Mounjaro List Price

Mounjaro (tirzepatide injection) is Eli Lilly's once-weekly dual GLP-1/GIP receptor agonist, FDA-approved for type 2 diabetes. In the SURPASS-2 trial (NEJM 2021) it lowered A1C and body weight more than semaglutide 1 mg at every dose. Lilly's wholesale acquisition cost (list price) is $1,112 per monthly fill at every dose, 2.5 mg through 15 mg (pricinginfo.lilly.com).

That is $237 a month below Wegovy's $1,349 list price and $26 above Zepbound's $1,086. Very few people pay list: insurance, the Lilly savings card and LillyDirect all bring it down.

How Much Is Mounjaro Without Insurance?

Without insurance Mounjaro costs $499 a month through LillyDirect, Lilly's own online pharmacy, and the price is the same at every dose (read October 13, 2026). Your doctor sends the prescription to LillyDirect Pharmacy and a dispensing partner ships the pens. At a retail pharmacy with no coverage you pay up to the $1,112 list price.

Unlike Zepbound, Mounjaro has no cheaper starting-dose tier on LillyDirect: the 2.5 mg starter pen is $499, the same as 15 mg.

Lilly Savings Card Terms (2026)

The Mounjaro savings card is for commercially insured patients only and has two tiers:

  • Insurance covers Mounjaro: as little as $25 for a 1-, 2- or 3-month fill. Savings are capped at $150 per 1-month fill and $1,950 per calendar year.
  • Insurance doesn't cover Mounjaro: as low as $499 a month. Savings are capped at $647 a month and $8,411 a year.
  • Not eligible: anyone enrolled in Medicare, Medicaid or another state, federal or government-funded program.
  • Expiry: the card expires and savings end on December 31, 2026.

Because the covered tier caps savings at $150 a month, a plan copay above about $175 leaves you paying the difference. Terms are from mounjaro.lilly.com, read October 13, 2026.

Zepbound: Same Drug, Weight Loss Label

Zepbound is the same molecule as Mounjaro (tirzepatide), approved for chronic weight management. In SURMOUNT-1 (NEJM 2022), adults without diabetes on the 15 mg dose lost an average of 20.9% of body weight over 72 weeks. Lilly prices it differently:

  • Zepbound list price: $1,086/month
  • LillyDirect self-pay: $299 at 2.5 mg, $399 at 5 mg, $449 at 7.5–15 mg (the higher doses need a refill within 45 days; vials and KwikPens)
  • Zepbound savings card: as little as $25/month with commercial coverage

Mounjaro vs Zepbound: Which to Ask For?

Ask for Mounjaro if: you have type 2 diabetes and commercial insurance that covers it — with the savings card you may pay $25.

Ask for Zepbound if: you are seeking weight loss and paying yourself — LillyDirect starts at $299, versus $499 for Mounjaro.

Full Zepbound pricing by dose: Zepbound cost guide.

Mounjaro with Insurance and Medicare

Coverage for Mounjaro is usually better than for weight-loss drugs because its approved use is type 2 diabetes. Expect prior authorization (often a documented A1C and a tried first-line drug such as metformin), and most plans will not cover Mounjaro prescribed off-label for weight loss.

  • Commercial insurance that covers it + savings card: from $25
  • Commercial insurance that doesn't cover it + savings card: $499
  • Medicare Part D or Medicaid: your plan's copay for type 2 diabetes; the savings card can't be used.

The Medicare GLP-1 Bridge, which launched July 1, 2026 at a $50 copay, covers Wegovy, Zepbound and Foundayo for eligible beneficiaries — not Mounjaro. Details: Medicare GLP-1 coverage 2026. If a plan denies Mounjaro, ask whether Zepbound is covered under its obesity benefit instead.

Compounded Tirzepatide Prices

Compounded tirzepatide uses tirzepatide as its active ingredient and is not FDA-approved, prepared by a licensed pharmacy for an individual prescription. Tracked telehealth providers list it from $129 to $399 a month; the weekly Price Index put the median at $230 across 21 compounded providers on November 11, 2026.

It is not an FDA-approved finished product. The FDA declared the tirzepatide shortage resolved on December 19, 2024 (declaratory order), so it is now compounded only under the standard patient-specific rules by a state-licensed 503A pharmacy or FDA-registered 503B facility. The full legal picture is in our generic tirzepatide guide.

Lowest-priced compounded tirzepatide (active listings)

Active listings first, then listings with an inactive link, each by price. A listing held last by publisher decision may follow.

  1. #1Embody$129/mo →
  2. #2CoreAge Rx$129/mo →
  3. #3TMates$167/mo →
  4. #4Sprout Health$199/mo →
  5. #5Bodybuilding.com Health+$209/mo →

Lowest advertised monthly price; the lowest rates usually need a 6- or 12-month plan. All options: cheapest tirzepatide without insurance.

Get personalized recommendations

Find compounded tirzepatide (not FDA-approved) from $129/mo. Match with a listed program in 2 minutes.

Find my match →

Full Price Comparison

Every way to get tirzepatide (Mounjaro or Zepbound) in 2026, cheapest first.

OptionMonthly CostFDA ApprovedHow to AccessNotes
Mounjaro + savings card (covered)
Tirzepatide pen
$25/moYesPharmacy + commercial insuranceSavings capped $150/mo, $1,950/yr; expires December 31, 2026
Zepbound + savings card (covered)
Tirzepatide
$25/moYesPharmacy + commercial insuranceWeight-loss indication
Zepbound via Medicare GLP-1 Bridge
Tirzepatide
$50/moYesMedicare, eligible beneficiariesLaunched July 1, 2026; Mounjaro not included
Compounded tirzepatide
Not an FDA-approved product
$129–$399/moNoTracked telehealth providersPatient-specific compounding (503A/503B)
Zepbound via LillyDirect
Vials or KwikPens
$299–$449/moYesLillyDirect.com$299 at 2.5 mg; $449 at 7.5–15 mg with 45-day refill
Mounjaro via LillyDirect
Tirzepatide pen
$499/moYesLillyDirect.comSelf-pay, same price every dose
Mounjaro + savings card (not covered)
Tirzepatide pen
$499/moYesPharmacy + commercial insuranceSavings capped $647/mo
Zepbound (retail, no insurance)
Tirzepatide
$1,086/moYesRetail pharmacyList price
Mounjaro (retail, no insurance)
Tirzepatide pen
$1,112/moYesRetail pharmacyList price; type 2 diabetes indication

Lilly prices recorded October 13, 2026; compounded prices from the GLP-1 Price Index (November 11, 2026). Retail prices vary by pharmacy.

Is There an Oral Mounjaro?

No. Tirzepatide is injection-only. If you want a pill, the FDA-approved options are Lilly's Foundayo (orforglipron, approved April 1, 2026) and Novo Nordisk's Wegovy pill (oral semaglutide), both from $149 a month self-pay at the starting doses. See Foundayo price and dosing.

The Cheapest Path to Tirzepatide

Ranked by monthly cost, from your situation:

1

Covered + savings card

Commercial insurance that covers Mounjaro (type 2 diabetes) or Zepbound (weight loss), plus Lilly's savings card.

As low as $25/mo
2

Compounded tirzepatide

The cheapest self-pay option, from tracked telehealth providers using licensed pharmacies. Not an FDA-approved product.

As low as $129/mo
3

Zepbound via LillyDirect

Brand tirzepatide for weight loss without insurance; $299 at 2.5 mg rising to $449 at 7.5 mg and above.

As low as $299/mo
4

Mounjaro via LillyDirect

Brand Mounjaro for type 2 diabetes without insurance, the same price at every dose.

As low as $499/mo

FAQ

How much does Mounjaro cost?
Mounjaro costs $1,112 a month at list price in 2026, the same at every dose. You pay as little as $25 with commercial insurance that covers it plus Lilly's savings card, $499 with commercial insurance that doesn't cover it, or $499 a month self-pay through LillyDirect. Compounded tirzepatide, which is not FDA-approved, starts at $129 a month from tracked telehealth providers.
How much is Mounjaro without insurance?
Without insurance Mounjaro is $1,112 a month at a retail pharmacy, or $499 a month self-pay through LillyDirect, Eli Lilly's own pharmacy, at every dose from 2.5 mg to 15 mg (read October 13, 2026). The savings card needs commercial insurance, so it does not help if you have none. For weight loss, Zepbound (the same molecule) starts at $299 a month on LillyDirect, and compounded tirzepatide starts at $129.
Can I use the Mounjaro savings card without insurance?
No. The card requires commercial insurance. With coverage for Mounjaro you pay as little as $25 for a 1-, 2- or 3-month fill (savings capped at $150 a month and $1,950 a year). With commercial insurance that does not cover Mounjaro you pay as low as $499 a month (savings capped at $647 a month and $8,411 a year). Anyone in Medicare, Medicaid or another government program is excluded, and the card expires December 31, 2026.
What is the difference between Mounjaro and Zepbound?
Mounjaro and Zepbound are the same molecule, tirzepatide, made by Eli Lilly. Mounjaro is FDA-approved for type 2 diabetes and Zepbound for chronic weight management and obstructive sleep apnea with obesity. The drug is identical; the label decides insurance coverage, which savings card applies and the LillyDirect price.
Is Mounjaro or Zepbound cheaper on LillyDirect?
Zepbound is cheaper at the starting doses: $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5 mg to 15 mg if you refill within 45 days. Mounjaro is $499 a month at every dose. Which one you can be prescribed depends on your diagnosis.
Does Medicare cover Mounjaro?
Medicare Part D plans can cover Mounjaro for type 2 diabetes under their own formulary and copay; the Lilly savings card cannot be used. The Medicare GLP-1 Bridge, which launched July 1, 2026 at a $50 copay, covers Wegovy, Zepbound and Foundayo for eligible beneficiaries, not Mounjaro.
Is compounded tirzepatide still legal?
Yes, under the standard patient-specific compounding rules. The FDA declared the tirzepatide shortage resolved on December 19, 2024, so pharmacies can no longer mass-produce copies under the shortage exemption; a prescriber writes an individual prescription and a state-licensed 503A pharmacy or FDA-registered 503B facility prepares it. Compounded tirzepatide is not an FDA-approved finished product. Tracked providers list it from $129 a month.
Will there be a generic version of Mounjaro?
No. The FDA Orange Book lists Lilly's tirzepatide compound patent (US 9,474,780) as expiring May 13, 2036, with formulation and method-of-use patents running to 2039 and one Mounjaro use patent to December 30, 2041, so a generic tirzepatide is not expected in the U.S. before 2036 at the earliest. Because tirzepatide is approved under an NDA, a copy would be an ANDA generic rather than a biosimilar.

Compare All GLP-1 Providers by Price

See how Mounjaro and Zepbound compare to Wegovy, Ozempic, and oral options at every price point.

Ready to start?

Compare the recorded costs, sources and evidence gaps for 52 listed providers. Confirm current terms with the provider before enrolling.

Embody (paid link)

from $49/mo, 12-month plan

Visit Embody